These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 19051213)

  • 1. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
    Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
    J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
    Chen JK; Hu LJ; Wang D; Lamborn KR; Deen DF
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1538-47. PubMed ID: 17394949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models.
    Stackhouse MA; Pederson LC; Grizzle WE; Curiel DT; Gebert J; Haack K; Vickers SM; Mayo MS; Buchsbaum DJ
    Gene Ther; 2000 Jun; 7(12):1019-26. PubMed ID: 10871750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
    Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
    Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit.
    Yin L; Fu S; Wang X; Nanakorn T; Won J; Deisseroth A
    Chin Med J (Engl); 2001 Sep; 114(9):972-5. PubMed ID: 11780394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy.
    Pandha HS; Cook D; Greenhalgh R; Dalgleish A
    BJU Int; 2005 Jun; 95(9):1336-43. PubMed ID: 15892827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
    Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.
    Hanna NN; Mauceri HJ; Wayne JD; Hallahan DE; Kufe DW; Weichselbaum RR
    Cancer Res; 1997 Oct; 57(19):4205-9. PubMed ID: 9331076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
    Pastorakova A; Hlubinova K; Altaner C
    Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
    Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
    J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression by HIF-1 activity depending on Sp1 in hypoxic breast cancer cells.
    Higashimura Y; Nakajima Y; Yamaji R; Harada N; Shibasaki F; Nakano Y; Inui H
    Arch Biochem Biophys; 2011 May; 509(1):1-8. PubMed ID: 21338575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity.
    Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J
    Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.
    Farrall AL; Whitelaw ML
    Oncogene; 2009 Oct; 28(41):3671-80. PubMed ID: 19668230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on the treatment of colon cancer by cytosine deaminase gene and 5-fluorocytosine].
    Huang JH; Wang Y; Li CH; Zhong DG; Lü HY
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):6-8. PubMed ID: 15771788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.